Loading clinical trials...
Loading clinical trials...
A Phase 2, Open-Label, Multi-Center Trial of Mavorixafor in Patients With WHIM Syndrome
Conditions
Interventions
X4P-001
Locations
2
United States
University of Washington Medical Center
Seattle, Washington, United States
St. Vincent's Hospital
Fitzroy, Victoria, Australia
Start Date
December 1, 2016
Primary Completion Date
June 16, 2022
Completion Date
June 16, 2022
Last Updated
October 30, 2024
Lead Sponsor
X4 Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions